Abstract 6391: Development of a novel strategy for cancer immunotherapy based on tumor immunogenicity improvement by HLA-drug interaction

MLA

Takeshi Susukida, et al. “Abstract 6391: Development of a Novel Strategy for Cancer Immunotherapy Based on Tumor Immunogenicity Improvement by HLA-Drug Interaction.” Cancer Research, vol. 83, Apr. 2023, p. 6391. EBSCOhost, https://doi.org/10.1158/1538-7445.am2023-6391.

APA

Takeshi Susukida, So-ichiro Sasaki, Tomohiro Shirayanagi, Shigeki Aoki, Kousei Ito, & Yoshihiro Hayakawa. (2023). Abstract 6391: Development of a novel strategy for cancer immunotherapy based on tumor immunogenicity improvement by HLA-drug interaction. Cancer Research, 83, 6391. https://doi.org/10.1158/1538-7445.am2023-6391

Chicago

Takeshi Susukida, So-ichiro Sasaki, Tomohiro Shirayanagi, Shigeki Aoki, Kousei Ito, and Yoshihiro Hayakawa. 2023. “Abstract 6391: Development of a Novel Strategy for Cancer Immunotherapy Based on Tumor Immunogenicity Improvement by HLA-Drug Interaction.” Cancer Research 83 (April): 6391. doi:10.1158/1538-7445.am2023-6391.